CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-13 | BARABE TIMOTHY C Director | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2023-11-13 | BARABE TIMOTHY C Director | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2023-11-13 | BARABE TIMOTHY C Director | Returned to the company · Stock Option (Right to Buy) | −87,500 | $0.93 | $81K | 0 |
| 2023-11-13 | COX CARRIE SMITH Director | Returned to the company · Stock Option (Right to Buy) | −20,000 | $0.74 | $15K | 0 |
| 2023-11-13 | COX CARRIE SMITH Director | Returned to the company · Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2023-11-13 | COX CARRIE SMITH Director | Returned to the company · Stock Option (Right to Buy) | −60,000 | 0 | ||
| 2023-11-13 | COX CARRIE SMITH Director | Returned to the company · Stock Option (Right to Buy) | −60,000 | 0 | ||
| 2023-11-13 | COX CARRIE SMITH Director | Returned to the company · Stock Option (Right to Buy) | −107,500 | $0.93 | $100K | 0 |
| 2023-11-13 | Kurtoglu Metin Chief Operations Officer | Grant or award · Stock Option (Right to Buy) | +6,414.68 | 6,414.68 | ||
| 2023-11-13 | Kurtoglu Metin Chief Operations Officer | Grant or award · Stock Option (Right to Buy) | +427.65 | 427.65 | ||
| 2023-11-13 | Kurtoglu Metin Chief Operations Officer | Grant or award · Stock Option (Right to Buy) | +427.65 | 427.65 | ||
| 2023-11-13 | Jewell Christopher M Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +4,276.45 | 4,276.45 | ||
| 2023-11-13 | Singer Michael Director | Grant or award | +110,123 | 110,123 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +197,663 | 197,663 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +29,212 | 29,212 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +3,670 | 3,670 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +49,555 | 49,555 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +49,555 | 49,555 | ||
| 2023-11-13 | Singer Michael Director | Other acquisition | +7,616 | 7,616 | ||
| 2023-11-13 | Singer Michael Director | Grant or award · Series A Non-Voting Convertible Preferred Stock | +6,304.56 | 6,304.56 |
Page 17 of 25 · 495 trades